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A B S T R A C T
Background
Cleft palate is the most common congenital deformity of the face. It could affect speech acquisition, resulting in articulation errors
that could persist into adulthood. Electropalatography (EPG) has been used in speech therapy with individuals who have articulation
problems that are unresponsive to “standard treatment” procedures.
Objectives
To determine the effectiveness of speech intervention using electropalatography (EPG) for treating articulation errors in individuals
with repaired cleft palate.
Search strategy
The following databases were searched: CENTRAL 2008 (Issue1), MEDLINE 1966 to March 2008, EMBASE 1974 to March 2008,
CINAHL 1982 to March 2008, PsycINFO 1967 to March 2008 and eight other databases. We handsearched Clinical Linguistics and
Phonetics (1987 to 2008, Issue 2), Cleft Palate Journal/ Cleft Palate-Craniofacial Journal (1980 to 2008, Issue 1), and the International
Journal of Language and Communication Disorders (1980 to 2008, Issue 1). We searched the EPG bibliography (Gibbon 2007). We
reviewed reference lists of relevant articles and approached researchers to identify other possible published and unpublished studies.
Selection criteria
Randomised controlled studies comparing EPG intervention to no treatment, delayed treatment, “standard treatment”, or alternative
treatment techniques for managing articulation problems associated with cleft palate in children or adults.
Data collection and analysis
One author searched the titles and abstracts and assessed trial quality. A second author checked judgements; disagreement was resolved
through discussion. Three authors were available to examine any potential trials for possible inclusion in the review.
Main results
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One trial using parallel design met the inclusion criteria of this review; no meta-analysis was performed. The study reported that fewer
therapy sessions were needed to achieve the treatment goals for the EPG therapy and frication display method (N = 2), followed by
EPG therapy (N = 2) and “standard treatment” (N = 2).
Authors’ conclusions
The included trial was a small-scaled study and there were serious limitations in the design andmethodology (e.g. allocation concealment
was unclear, blinding of outcome assessor(s) was not ensured, few quantitative outcome measures were used, and the results were not
reported as planned). Therefore, the current evidence supporting the efficacy of EPG is not strong and there remains a need for high-
quality randomised controlled trials to be undertaken in this area.
P L A I N L A N G U A G E S U M M A R Y
Electropalatography for articulation disorders associated with cleft palate
A cleft palate means that during the early stages of pregnancy, the baby’s roof of the mouth does not join in the normal way. The lip
is sometimes cleft as well as the palate. Children who are born with a cleft lip or palate usually have corrective surgery during the first
few years of life. Nowadays, surgery is so good that there are few long term consequences.
However, some children with repaired cleft palate can have difficulties with speech as they get older. One type of speech difficulty affects
consonants formed by the tongue in the mouth, such as /t/, /d/, /s/. This makes words like “toe”, “door” and “sun” sound distorted
or even unrecognisable to listeners. These consonants can be difficult to correct, even by experienced speech and language therapists.
Any long term speech difficulties are likely to have a negative effect on children’s social, psychological and educational development
and future prospects.
One technique that may help to correct these abnormal articulations is electropalatography or EPG. EPG is a computer-based technique
that can display the tongue’s contact with the hard palate (roof of the mouth) during speech. It involves the child wearing an adapted
dental plate, with sensors on the surface. When the tongue contacts the sensors, distinctive patterns for consonants are displayed on a
computer screen. The patterns can be used in speech therapy to provide visual feedback so that children can learn normal patterns for
consonants they find difficult.
It is not known whether EPG benefits children with cleft palate. Such information is important for speech and language therapists
who may want to use the technique in their clinical practice. The review reveals that at present there are no high quality (randomised
controlled trial) studies in this field to enable conclusions to be drawn about the efficacy of treatment using EPG for children with cleft
palate.
B A C K G R O U N D
Description of the condition
Cleft palate is the most common birth defect and the most com-
mon congenital deformity of the face (Kummer 2001). Its inci-
dence varies from 1:500 to 1:2000, depending on racial back-
ground and gender (Marazita 2004). Cleft palate occurs when the
roof of the mouth has not joined completely due to abnormal fa-
cial development during the fourth to twelve weeks of the gesta-
tion period. The cleft “can range from just an opening at the back
of the soft palate to a nearly complete separation of the roof of
the mouth (soft and hard palate)” (CLAPA 2001). It may occur
on one side (unilateral) or on both sides (bilateral). Cleft palate
is usually closed surgically by the age of 18 months (Seagle 2004;
Watson 2001). However, the timing of surgical intervention varies
between centres (Liao 2006).
Cleft palate and syndromes
Cleft palate may be associated with other congenital anomalies,
and may occur as a part of a well-defined syndrome, such as ve-
locardiofacial syndrome. To date, there are more than 400 syn-
dromes that include cleft palate as a feature (Winter 2000) and
this accounts for about 30% of the cleft cases. Individuals born
with cleft palate are more likely to have cognitive deficits than
normal children, with an even higher risk in children born with
a syndrome (Endriga 1999), possibly due to aberrant brain devel-
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opment (Nopoulos 2002) and other factors. Cognitive problems
associated with various types of learning disabilities can add to the
detrimental effect of palatal cleft on speech acquisition.
Compensatory misarticulations
The impact of cleft palate on speech acquisition is apparent early,
at the stage of pre-speech vocalisations, and its influence may con-
tinue even after surgical intervention (Peterson 2006). It has been
estimated that normal articulation can be expected in 25% of
preschoolers with repaired cleft palate who receive routine care
by a cleft palate team, but “a significant number of individuals
will continue to demonstrate problems with articulation in adoles-
cence” (Peterson 2001). Compensatory misarticulations are one of
the prominent articulation problems observed in individuals with
a history of cleft palate. The prevalence of compensatory misartic-
ulations in English-speaking children born with cleft palate varies
from 22% to 28% (Dalston 1992; Hardin-Jones 2005; Peterson
1990) and a recent study reported a prevalence of 28.5% inGreek-
speaking children (Paliobei 2005).Compensatorymisarticulations
are learned articulation deviations and most of them are errors
in place of articulation (Peterson 2006). For example, the sound
/t/ is backed from the alveolar region to the velar region, hence,
listeners perceived a /k/ sound. They are believed to result from
strategies developed by individuals with cleft palate as a response
to inadequate intraoral pressure for normal articulation caused
by the structural deficit (Warren 1990). Once learned, these ab-
normal learned patterns can persist due to habituation (Peterson
2001). Since compensatory misarticulations are due to abnormal
learning, they are under the speaker’s control and, therefore, can
respond to speech therapy (Kummer 2001).
Description of the intervention
Speech therapy
It is estimated that between 50-75% of individuals born with cleft
palate require speech intervention at some point in their lives (
Peterson 2001; Witzel 1991). Based on a comprehensive speech
assessment, speech-language therapists (SLTs) apply phonetic and
phonological approaches and principles of behaviourmodification
in speech therapy (Sell 2001). The SLTs teach directly the target
speech sounds to the individuals, with the aid of different tech-
niques and tools such as tactile cues, the use of mirror, and dia-
gram of the oral cavity. Once the target production is established,
the sound is practised and stabilised in a hierarchical progression
of speech contexts, from syllables through words, phrases, sen-
tences to spontaneous speech (Peterson 2006). The SLTs also work
with the individuals on their speech sound discrimination and
self-monitoring skills in order to establish internal mechanisms
for correct target selection and perceptual-motor self-monitoring
(Sell 2001). However, not all individuals with compensatory er-
rors respond well to this “standard treatment” approach; posterior
articulation pattern persists in some individuals despite of years of
speech therapy (Sell 2001). Especially in adolescents and adults,
modification is more likely to occur if some type of biofeedback
therapy, such as speech therapy using electropalatography (EPG),
is provided.
Using EPG for speech assessment and therapy
EPG is a computer-based instrument which gives information on
the location and timing of the tongue’s contact with the hard
palate during speech (Hardcastle 1991; Hardcastle 1997). It has
been used to assess lingual articulation and to treat articulatory
disorders through the use of visual feedback (a type of biofeed-
back) during speech therapy. Each patient undergoing EPG as-
sessment or therapy has to wear a custom-made artificial dental
plate which is moulded to fit the speaker’s hard palate. The dental
plate is embedded with electrodes on the lingual surface. When
the electrodes are contacted by the tongue during speech, a signal
is sent to an external processing unit through lead-out wires and
real-time visual feedback of the location and time of tongue-palate
contacts is shown on a computer monitor. The SLTs use this visual
display to teach their clients to establish new, appropriate articu-
latory pattern for the speech sounds targeted for treatment.
How the intervention might work
The use of biofeedback in speech therapy is a clinical application of
cybernetic theory, which views behavioural and physiological ac-
tivity and learning as self-regulated processes that involve specific
organically based control mechanisms (Davis 1980, Smith 1967,
Wiener 1948). Speech production has been described as a self-
regulating, closed-loop or servo- system (Fairbanks 1954, Mysak
1959). The system contains a “comparator” where the input sig-
nal and feedback signals of the output (i.e.e.g. auditory, tactile,
and proprioceptive feedback) are compared; the presence of differ-
ence between them indicates the occurrence of errors. Appropriate
information is then sent to a “mixer” which combines the error
signal and input signal to alter the operation of the “effectors”
(i.e. the anatomical structures involved in respiration, phonation,
resonance and articulation; Fairbanks 1954, Mysak 1959). Inter-
ruption of the speech control mechanism may cause disturbances
of speech production, resulting in, for example, articulation er-
rors. Speech problems can be managed by using biofeedback in
speech therapy. Biofeedback involves the use of instrumentation
(e.g. EPG) to give explicit, real-time information about a specific
physiologic system (e.g. tongue-palate contact) that is under the
control of the nervous system but not clearly or accurately per-
ceived by the individual (Davis 1980). The individual can then
make use of the information to facilitate the control of the response
(e.g. articulation). Biofeedback has been employed in managing
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various communication problems, such as voice disorders and flu-
ency disorders (Davis 1980).
Why it is important to do this review
The real-time visual feedback provided by EPG has been used
in speech therapy with individuals who have abnormal articula-
tions that are unresponsive to “standard treatment” procedures (
Stengelhofen 1990). Although there exists substantial literature
about speech intervention using EPG, there has not been a sys-
tematic review of the effectiveness of EPG, hence, it remains un-
known whether EPG is beneficial and as a result it is difficult for
SLTs to make decisions about whether or not to use EPG in their
clinical practice. Therefore, this review aimed to assess the effec-
tiveness of EPG in speech therapy for treating articulation errors
for individuals with articulation disorders related to cleft palate.
O B J E C T I V E S
To assess the effectiveness of electropalatography (EPG) in im-
proving the treatment of articulation errors in individuals with
repaired cleft palate.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials in which participants have been ran-
domly allocated to different treatment conditions by, for example,
using a random number table.
Types of participants
Individuals with articulation problems associated with cleft palate.
Included were individuals with recognized syndromes (e.g. velo-
cardiofacial syndrome, Treacher Collins syndromes, etc). There
was no restriction on age range.
Those with learning disability associated with severely limited ex-
pressive/spoken language (as judged by SLTs using informal or
standardised language test) or severe hearing impairment were ex-
cluded from the review purely on the assumption that a certain
level of cognitive abilities of the individuals is required in order
for them to benefit from EPG therapy.
Types of interventions
Interventions using EPG compared to no treatment, delayed treat-
ment, “standard treatment”, or alternative treatment techniques
(e.g. treatment using ultrasound).
There was no restriction on the frequency, intensity and duration
of speech intervention.
Types of outcome measures
Primary outcomes
The primary outcome is the measure of correct articulation of
speech sounds targeted in therapy, which could be assessed by:
• Standardised articulation tests (e.g. Edinburgh Articu-
lation Test (Anthony 1971) );
• Other perceptual evaluation of articulation (e.g. Cleft
Audit Protocol for Speech, percentage of consonants
correct);
• Articulatory accuracy based on instrumental measures,
such as electropalatography (EPG);
• Measures of speech intelligibility (e.g. by means of a
perceptual rating scale, or by calculating the number of
words correctly transcribed by examiner).
Secondary outcomes
• Measures of listener acceptability (e.g. by using a per-
ceptual rating scale);
• Participants’ perceptions of impact of wearing the EPG
plate on (i) speech production, (ii) tongue movement,
(iii) sensation in the mouth, (iv) self-perceived appear-
ance, (v) gagging, and (vi) saliva;
• Adverse effects.
Outcome measures of interest did not form part of the inclusion
criteria.
Search methods for identification of studies
Electronic searches
We searched the following databases:
• The Cochrane Central Register of Controlled Trials
(The Cochrane Library Issue 1, 2008)
• MEDLINE (1966 to March 2008)
• EMBASE (1974 to March 2008)
• ERIC (1966 to March 2008)
• PsycINFO (1967 to March 2008)
• CINAHL (1982 to March 2008)
• Linguistics and Language Behaviour Abstracts (LLBA)
(1973 to March 2008)
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• Allied and Complementary Medicine (AMED) (1985
to March 2008)
• Latin American Health Sciences Literature (LILACS)
(1982 to March 2008)
• Japana Centra Revuo Medicina (1983 to February
2008)
• TheNational Research Register (searchedMarch 2008)
• ClinicalTrials.gov (searched March 2008)
• Dissertation Abstracts (1861 to March 2008)
The following search terms were used to identify articles. No lan-
guage or date restriction was applied. RCT filters were not used as
it was felt that they would restrict the search leading to potentially
useful records possibly being missed.
1. cleft palate
2. electropalatograph*
3. EPG
4. palatograph*
5. palatomet*
6. 2 or 3 or 4 or 5
7. 1 and 6
The search stratagies for the individual databases can be found in
Appendix 1, Appendix 2, Appendix 3, Appendix 4, Appendix 5,
Appendix 6, Appendix 7, Appendix 8, Appendix 9, Appendix 10,
Appendix 11, and Appendix 12.
Searching other resources
We handsearched three journals from 1980 onwards - Clinical
Linguistics and Phonetics (1987 to 2008, Issue 2), Cleft Palate
Journal/ Cleft Palate-Craniofacial Journal (1980 to 2008, Issue
1), and the International Journal of Language and Communica-
tion Disorders (1980 to 2008, Issue 1). The Master List of Jour-
nals (http://www.cochrane.us/masterlist.asp) was checked to en-
sure that they had not been handsearched by The Cochrane Col-
laboration. We searched the EPG bibliography (Gibbon 2007).
We reviewed reference lists of relevant articles and approached col-
leagues and researchers to identify other possible published and
unpublished studies such as technical or research reports, confer-
ence papers, and different types of dissertations. There was no lan-
guage restriction; no translation was sought since no non-English
potential study was identified.
Data collection and analysis
Selection of studies
AL conducted the electronic search and FG was in charge of the
handsearch. All references generated from the search strategy were
managed using a reference management programme. AL indepen-
dently examined the studies against the inclusion criteria. The
judgements were then checked by FG and any disagreement was
resolved through discussion. Full text version was obtained for
articles that appeared to have met the inclusion criteria or those
that seemed to be uncertain if they have met the inclusion criteria.
Articles that did not fulfil the inclusion criteria were discarded.
The reviewers were not blinded to the name(s) of the author(s),
institution(s) or publication source at any level of review.
Data extraction and management
A paper data extraction form was developed for extracting the
following information:
Participants
1. Number of participants
2. Age
3. Sex
4. Inclusion and/or exclusion criteria
5. Level of severity of articulation disorders
6. Reason(s) for patients being rejected, if applicable
7. Other baseline characteristics of the participants re-
ported e.g. hearing ability
Methods
1. Type(s) of speech assessment conducted
2. Assessment findings (e.g. number and types of articula-
tion errors, such as double articulation, palatalization)
Interventions
1. Type of interventions
2. Length of intervention i.e. number of hours of the
course of speech therapy
3. Number of therapy session
4. Whether compliance evaluated
Outcomes
1. Total numbers and events for each intervention group
or risk ratio and its error (binary outcomes)
2. Mean and deviation (continuous data)
Assessment of risk of bias in included studies
AL independently assessed the risk of bias in each included study
under the following six domains. FG checked and agreed with the
judgements. JL was available for consultation in case there was
disagreement between AL and FG and a consensus between them
could not be reached.
The assessment of risk of bias consisted two parts: (1) a succinct
description, which included verbatim quotes from reports or cor-
respondence and/or a comment from the reviewer, of the proce-
dures conducted to avoid bias; and (2) a judgement of the risk of
bias based on part 1. A judgement of ’Yes’ means that there was
low risk of bias in the study; whereas ’No’ indicates a high risk
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of bias in the included study (see also the Cochrane Handbook,
Higgins 2008). A judgement of ’Unclear’ means that the risk of
bias was uncertain due to insufficient information available for the
judgement. The judgement criteria for each domain are described
below.
Sequence generation
The method used to generate the allocation sequence was de-
scribed using quotes wherever possible. Comment, such as “prob-
ably done” or “probably not done”, was added to supplement any
ambiguous quote. Each included study was assigned to one of the
following categories:
• ’Yes’ indicates adequate method was used for randomi-
sation e.g. using computer generated or table of random
numbers.
• ’Unclear’ indicates uncertainty about whether appro-
priate method of randomisation was used.
• ’No’ indicates that inadequatemethodof randomisation
was used e.g. case file number, date of birth, or alternate
numbers.
Allocation concealment
The included studies was assigned to one of the following quality
criteria whereby:
• ’Yes’ indicates adequate concealment of allocation e.g.
prenumbered or coded identical containers adminis-
tered serially to participants.
• ’Unclear’ indicates uncertainty about whether the allo-
cation was adequately concealed e.g. the authors did not
describe the allocation methods.
• ’No’ indicates that the allocation was not adequately
concealed e.g. alternate assignment.
For those studies assessed as ’Unclear’ or ’No’, the pre-treatment
assessment and the allocation of participants was described in the
review (Description of Studies) in order to identify differences
between intervention and control groups that can be ascertained
at baseline.
Blinding
Blinding of participants and healthcare providers (i.e. the SLTs)
is not possible for EPG therapy but blinding of outcome asses-
sor(s) and data analyst(s) from knowledge of which intervention a
participant had received should be ensured. The measures used to
ensure blinding were described and evaluated. This domain was
graded as ’Yes’, ’Unclear’, or ’No’. Assessment was made for each
main outcome (e.g. outcome measured at 6 months post-therapy,
outcome measured at 12 months post-therapy).
Incomplete outcome data
Incomplete outcome data refers to those that were due to attrition
(drop-out) during the study, or exclusions from the analysis. Pro-
tection from attrition bias includes:
• Attrition described, proportion smaller than 10% of
assigned patients and difference between the two groups
not greater than 10%.
• Reason(s) of participants withdrawal explained.
• Attrition appropriately analysed (e.g. intention-to-treat
analysis).
Selective reporting bias
This is also known as within-study publication bias. It may arise
in several ways (Higgins 2008):
• Only some of the analysed outcomes were included in
the study.
• Different time points at which the outcome was mea-
sured, or different instruments or assessors employed to
measure the outcome at the same time point.
• Selective reporting of analysis using the same data.
• Selective reporting the results of sub-scales of full mea-
surement scale or a subset of events.
• Some outcomes were reported but with inadequate de-
tail for the data to be included in a meta-analysis.
Other sources of bias
Other possible sources of bias include:
• Baseline imbalance - measures used to ensure the groups
compared in the study were similar at baseline in terms
of severity of articulation problems and other baseline
characteristics (e.g. hearing ability) would be described.
• Early stopping - incidence of early stopping of inter-
vention and the reason(s) for stopping early would be
described.
• Co-intervention - whether some of the participants
received additional intervention (e.g. speech therapy)
would be described.
Measures of treatment effect
Further analysis was not carried out as only one trial was identified.
Methods planned in the protocol are included below and they will
be used in future updates.
Binary data
Binary data may be likely (e.g. “articulation improved versus no
change”). The data will be analysed by calculating the risk ratio.
Continuous data
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Standardised articulation test results, articulation accuracy based
on EPG or perceptual evaluation, judgement of speech intelligi-
bility and listener acceptability will be treated as continuous data.
Weighted mean difference (WMD, or the ’difference in means’)
will be calculated if the outcome measurements in all studies are
made on the same scale. Otherwise, standardised mean differences
(SMD) will be used to combine studies that measured the same
outcome using different methods.
Unit of analysis issues
Cluster-randomised trials
Clustering effects should be taken into account by analysing the
data using appropriate statistical approaches (e.g. using two-sam-
ple t-test to compare the means of the clusters in the intervention
group to those in the control group at cluster-level; ormixed effects
linear regression approach at individual-level; Donner 2000). The
author(s) will be contacted in case this was not described clearly
in the study. If appropriate controls of clustering were not used,
individual participant data will be requested and re-analysed using
multilevel models (Donner 2000). The results will be combined
with those from individually randomised trials for meta-analysis if
the clinical heterogeneity between studies is small (Donner 2001).
Cross-over trials
Cross-over trials are not appropriate for intervention that can have
a lasting effect (Higgins 2008). Therefore, this design is not suit-
able for studying interventions for treating articulation problems.
Studies with multiple treatment groups
Since three comparisons were planned (see Data analysis below),
the “shared” group (i.e. the group that received EPG therapy)
will be split into two or more groups of smaller sample size for
independent comparisons (Higgins 2008).
Dealing with missing data
Authors will be contacted and asked to supply missing data. In the
event that the authors could not be contacted or data could not
be supplied, missing data and drop-outs will be assessed for each
included study and the number of participants who were included
in the final analysis as a proportion of all participants in each study
will be reported. Where known, reasons for missing data will be
provided.
Assessment of heterogeneity
Clinical heterogeneity will be assessed by examining the types of
participants, the severity of articulation errors, interventions, and
outcome measures as specified in the criteria for included stud-
ies. The consistency across studies will be assessed using the Chi-
squared test for heterogeneity, through visual inspection of for-
est plots, and by using I2 test (Higgins 2002, Higgins 2003). I2
is a quantity that describes the percentage of variability in point
estimates that is due to heterogeneity rather than sampling error.
If there is evidence of heterogeneity (i.e. an I2 value of 25% or
greater), the possible causes of heterogeneity will be explored by
examining the studies and data again and where appropriate con-
ducting subgroup analyses.
Assessment of reporting biases
Funnel plots (effect size against error) will be drawn if sufficient
studies were found. An asymmetric funnel indicates a relationship
between effect size and study size, which suggests the possibility of
either publication bias or a systematic difference between smaller
and larger studies. If a relationship was identified, the clinical
diversity of the studies will also be examined (Egger 1997).
Data synthesis
Data analysis
The following comparisons will be made:
1. EPG therapy versus delayed or no treatment
2. EPG therapy versus “standard treatment”
3. EPG therapy versus alternative treatment technique
Meta-analysis
Meta-analysis will be carried out using the RevMan 5.0 statistical
package, if there are sufficient data. A fixed effects model will be
used for analysis. If there is statistical heterogeneity which cannot
be explained (e.g. by means of subgroups), a random effects meta-
analysis will be used to incorporate heterogeneity among studies. A
random effects meta-analysis model assumes that the effects being
estimated in the different studies are not identical but follow some
common distribution.
Subgroup analysis and investigation of heterogeneity
If possible, subgroup analyses will be conducted to assess the im-
pact of individual’s age and intensity of therapy (number and fre-
quency of speech therapy sessions). Interpretation of the findings
from multiple subgroup analyses will consider the possibility of
false positive findings (Higgins 2005).
Sensitivity analysis
Sensitivity analyses will be performed to assess the robustness of
conclusions by examining the impact of study quality. The fac-
tors that are considered as important to study quality include ran-
domisation, blinding to outcome assessment, and attrition (Juni
2001). Studies which are categorised as (A) or (B) for these factors
in the methodological quality assessment will be included in the
analysis.
7Electropalatography for articulation disorders associated with cleft palate (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
See also Figure 1 for a summary of the results of the search and the
Characteristics of included studies and Characteristics of excluded
studies tables.
Figure 1. Tree diagram summarising the results of the literature search.
Results of the search
The literature review identified 112 titles - 84 titles through elec-
tronic searches, 25 from the EPG bibliography (Gibbon 2007),
and 3 were identified from relevant EPG studies (Michi 1986,
Michi 1993, Yamashita 1992). The studies were examined and
two were initially judged to havemet the inclusion criteria: a study
by Gibbon and colleagues (Gibbon 2001) and a study by Michi
and associates (Michi 1993). However, the Gibbon et al. study
was excluded because cross-over design, which is considered as in-
appropriate for studying speech intervention, was used. Thus, the
Michi et al. study is the only trial included in this review.
Included studies
Participants
All participants (N = 6) in Michi et al.’s study were Japanese-
speaking children, aged 4-6 years (Michi 1993). None of them has
any significant additional impairment, such as mental disability
or hearing impairment. All participants had compensatory misar-
ticulations associated with cleft palate.
Interventions
Michi et al. used parallel group design and compared three treat-
ment conditions: (1) EPG and friction display method, (2) EPG
therapy and (3) no-visual-feedback method. The participants re-
ceived a 60-minute individual therapy session once per week, ex-
cept for one participant who was given daily treatment in order to
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accommodate his schedule (Michi 1993).Michi et al. used the real-
time EPG contact pattern display as a visual feedback to aid the
teaching of the appropriate tongue placement for speech sound /s/.
There were four stages in the treatment, where the initial stage was
to establish the production of an intermediate simplified pattern
and the final stage aimed at the production of a nearly normal pat-
tern using appropriate direction and amount of air stream. Speech
stimuli of different linguistic complexity were gone through at
each stage in a hierarchy from isolated sound, through syllable to
word level (Michi 1993). The EPG and frication display method
includedEPG therapy and the use of waveformmodels of frication
produced by a speech-language pathologist as visual feedback for
treating frication production. The no-visual-feedback method did
not involve the use of any additional technique or equipment in
the therapy and therefore it is considered as “standard treatment”.
Outcome measures
The outcomemeasures included: (1) percent correct tongue place-
ment, as judged by examining the EPG patterns, and (2) percent
correct production of frication, as determined by perceptual judge-
ment (Michi 1993). A baseline over one month was established
and the progress was assessed at the onset and end of each therapy
session (Michi 1993).
Excluded studies
Most of the titles found through literature search were not treat-
ment studies - theywere studies that investigated the tongue-palate
contact patterns in normal articulations, or in articulation errors
associated with cleft palate with comparison to some normative
EPG data. Seventeen of the titles were on EPG treatment for ar-
ticulation problems associated with cleft palate. These potentially
relevant studies were examined but they were excluded from this
review because one used cross-over design (Gibbon 2001), which
is inappropriate for evaluating speech intervention, and the other
15 titles are not randomised controlled trials: nine were single case
study (Dent 1992, Gibbon 1989, Gibbon 1998,Hardcastle 1989,
Michi 1985, Michi 1986, Ohira 1989, Scobbie 2004, Whitehill
1996); four were case study series (Fujiwara 2007, Schmidt 2007,
Stokes 1996, Yamashita 1988); and two were before and after
study, with control group (Michi 1990, Yamashita 1999).
Risk of bias in included studies
See also the Risk of bias table of the included studies.
Allocation
Michi et al. stated explicitly that randomisation was used to as-
sign participants to different treatment conditions, however, the
method of randomisation was not specified in the study (Michi
1993). Hence, adequate allocation concealment is unclear.
Blinding
Michi et al. did not state whether the second author was blinded
to treatment allocation at the time of outcome assessment (Michi
1993).
Follow up and exclusions
No drop-out was reported in the study (Michi 1993).
Selective reporting
Michi et al. did not report all results of the treatment outcomes as
planned. The authors mentioned the measure of percent correct
production for tongue placement and frication for assessing the
treatment progress in theMethod section. However, they reported
the number of therapy sessions each participant required to achieve
the targets for some of the stages of the interventions (Michi 1993).
Some charts were included to provide additional information on
this but they were difficult to interpret.
Other potential sources of bias
All participants showed the same type of articulation errors before
the intervention began (Michi 1993). No early stopping of inter-
vention and co-intervention were reported.
Effects of interventions
Meta-analysis was not performed as only one study was included
in this review. The Michi et al. study used a descriptive method
to assess the treatment outcome and no statistical analysis was
conducted (Michi 1993).
Primary outcomes
1. Standardised articulation tests
Michi et al. did not use any standardised articulation test to mea-
sure the treatment outcome.
2. Other perceptual evaluation of articulation
Percent correct production
Michi et al. measured the percent correct production for tongue
placement based on visual inspectionof EPGpatterns and frication
based on perceptual judgement made by the second author of the
study at the start and end of each therapy session (Michi 1993).
A criterion of at least 80% accuracy was used for determining
whether the treatment should progress to the next level or not.
However, in the Results section, the authors reported mainly the
number of therapy sessions each participant required to achieve
the treatment target for some of the stages of the interventions.
See Additional Table 1 for details.
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Table 1. A summary of the number of therapy sessions required for each stage of the interventions included in the study
by Michi et al. (1993). “a” means that the information was not reported and “b” means that the target was attained and the
treatment progressed to the next stage within the same session.
Intervention Subject Stage I Stage II Stage III Stage IV
EPG therapy
and frication display
method
1 3 1 a a
4 3 5 a a
EPG therapy 2 11 a a a
5 b b 5 2
No-visual-feedback
method/“standard
treatment”
3 b b 4 6
6 b b 5 7
3. Articulatory accuracy based on EPG
Michi et al. did not use any of these measures to assess treatment
outcome.
4. Measures of speech intelligibility
Michi et al. did not measure speech intelligibility to assess treat-
ment outcome.
Secondary outcomes
Michi et al. did not measure listener acceptability, participants’
perceptions of impact of wearing the EPG plate and adverse effects
in their study.
D I S C U S S I O N
Individuals with a history of cleft palate are likely to exhibit articu-
lation problems, which could hamper communication and impair
self-esteem. Articulation problems due to abnormal learning do
not resolve spontaneously after surgery and they could be resistant
to speech intervention as well. It could be frustrating for these in-
dividuals and their family members to go through years of therapy
and achieve only a small progress. Alternate intervention approach
that could manage these persistent articulation problems more ef-
fectively and reduce the therapy time is of immense importance
for improving the service delivery, which would in turn benefit
the various stakeholders in healthcare. This review aimed to ad-
dress this issue by evaluating the effectiveness of electropalatogra-
phy (EPG) in treating articulation disorders associated with cleft
palate.
Summary of main results
A comprehensive search of literature revealed a number of EPG
intervention studies for cleft palate. However, most of them em-
ployed either single-case or small-N research design.Only one ran-
domised controlled trial met the inclusion criteria of the present
review (Michi 1993) and, therefore, meta-analysis was not per-
formed. The Michi et al. study used a descriptive approach to
evaluate the treatment outcome and no statistical analysis was
conducted. The authors reported that less therapy sessions were
needed to attain treatment goals for the EPG and frication dis-
play method, followed by the EPG method and no-visual-feed-
back method/“standard treatment” (Michi 1993). There was no
report of any harm or adverse effect brought by the EPG therapy
in the study.
Overall completeness and applicability of
evidence
The Michi et al. study included only children with articulation
errors associated with cleft palate as subjects (Michi 1993). This
is clinically relevant to a certain extent as SLTs usually have more
paediatric clients than adult clients in their caseload but the evi-
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dence is not complete, as the findings for childrenmay not be gen-
eralisable to adult clients. Moreover, the study had not included
individuals with recognized syndromes, such as velocardiofacial
syndrome, hence, it is uncertain if EPG therapy would benefit this
group of clients.
Relevant interventions for treating articulation problems associ-
ated with cleft palate have been investigated in the included trial.
In clinical practice, “standard treatment” is the conventional treat-
ment approach; EPG therapy may be given to clients who show
persistent articulation errors if the clinic is equipped with an EPG
machine, the clinician has been trained in using EPG for treat-
ment and resources are available for making an EPG plate for the
clients.
For the types of outcomemeasures, the included trial (Michi 1993)
used limited number of assessment methods and the measures
are based on EPG (except perceptual judgement of frication pro-
duced). Additional parameters, such as standardised articulation
tests, speech assessment protocol specific for cleft palate (e.g. Cleft
Audit Protocol for Speech used in the UK), measures of speech
intelligibility and listener acceptability, were not included. These
parameters are important, for example, standardised tests are often
used for evaluating the outcome of speech therapy and surgical
treatment for cleft palate management; perceptual judgement of
speech intelligibility and listener acceptability could provide in-
formation on the change in overall speech production as a result of
the change in tongue-palate contact patterns. Hence, they should
have been included for evaluating treatment outcome.
Quality of the evidence
There were a number of limitations in the methodology of the in-
cluded study (Michi 1993). First, the details of allocation conceal-
ment were not provided and blinding of outcome assessor(s) was
not employed. As stated above, few quantitative outcomemeasures
were used to show the effect of treatment on improving articula-
tion or speech intelligibility. In addition, the results of the outcome
measure were not reported as planned. Furthermore, generalisa-
tion and maintenance of treatment effect were not assessed. The
sample size was very small and there was no attempt to calculate
the size of sample required before subject recruitment. Consider-
ing these serious limitations in methodology, the level of quality
of the evidence provided by the included trials is judged to be very
low (Higgins 2008).
Potential biases in the review process
Every attempt has been made to identify studies that meet the
inclusion criteria.
Agreements and disagreements with other
studies or reviews
Other EPG treatment studies are the 16 titles that were being ex-
cluded from this review - 15 case reports and one cross-over trial.
No systematic review on speech therapy using EPG has been con-
ducted previously. There are two brief overviews of EPG as a clini-
cal tool: (1) the NICE (National Institute for Clinical Excellence)
interventional procedures overview of electropalatography, pub-
lished in 2002 (NICE 2002), and (2) the Royal College of Speech
and Language Therapists Clinical Guidelines (RCSLT 2005).
The main findings of the included study was that fewer therapy
sessions were needed to achieve the treatment goals when EPG
was used in therapy, as compared to “standard treatment” (Michi
1993). This is in congruence to the finding of two case studies con-
ducted by Yamashita and colleagues (Yamashita 1988; Yamashita
1999). Other studies also commented that rapid improvement in
articulatory patterns was observed during EPG therapy (Fujiwara
2007; Michi 1986; Stokes 1996; Whitehill 1996).
The included study had not investigated the efficacy of EPG in
terms of generalization but two case studies had done so and they
reported generalization of articulatory pattern from treated targets
to untreated speech sounds (Stokes 1996; Whitehill 1996). How-
ever, generalization of newly-learned articulatory patterns into ev-
eryday speech during the course of EPG therapy was found to
be poor for most individuals according to a case study (Michi
1990) and a survey on the SLTs’ views on EPG therapy outcomes
(Gibbon 2006).
The possibility of adverse effect that EPG may have on individ-
uals undertaking this intervention had not been explored in the
included study and other previous EPG treatment studies. How-
ever, the NICE interventional procedures overview of EPG com-
mented that this “technique is non-invasive and is unlikely to have
severe adverse effects” (NICE 2002).
Overall, the included study and the excluded 16 studies were in the
same view that EPG is a useful technique for treating persistent ar-
ticulation errors. The Michi et al. study and the 15 case studies re-
ported ‘success’ using EPG therapy. The cross-over study reported
‘success’ in most of the participants - nine out of 12 showed pos-
itive change in the articulatory patterns of the target sounds and
three showed no change after the EPG therapy (Gibbon 2001).
While for “standard treatment”, one participant showed positive
change post-intervention, one showed negative change and the
rest did not respond to this intervention (Gibbon 2001). This is
supported by the SLTs’ own clinical experience that the majority
of children and adults who received EPG therapy showed at least
some success in improving their articulation (87.5%; N = 21) and
a small number of individuals (12.5%; N = 3) showed no change
in their articulation following the intervention (Gibbon 2006).
Clinicians who had used EPG in speech therapy also indicated that
the technique had improved their clients’ awareness of their artic-
ulation difficulties (Gibbon 2006; Stokes 1996; Whitehill 1996)
motivation for therapy (Michi 1993; Whitehill 1996).
Finally, both NICE interventional procedures overview and RC-
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SLT Clinical Guidelines concluded that there was limited, low-
level evidence regarding the efficacy of EPG therapy (NICE 2002;
RCSLT 2005). The RCSLT Clinical Guidelines recommended
further research on the efficacy of EPG therapy. Meanwhile, they
suggested “electropalatography should be a treatment option for
school-aged children and older patients with persistent articula-
tory disorders” (RCSLT 2005).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
To date, the best evidence for the effectiveness of EPG therapy for
treating articulation problems associated with cleft palate was one
randomised controlled study (Michi 1993). However, the study
was of small-scale and there were a number of limitations in the
methodology. Despite the recommendation made by the RCSLT,
the evidence supporting the efficacy of EPG is not strong and does
not support the widespread use of EPG for treating articulation
disorders associated with cleft palate. It is recommended that ap-
propriately designed randomised controlled trials should be un-
dertaken before this technique is introduced as part of the routine
care of patients with repaired cleft palate.
Implications for research
Similar to the situation reported in other areas of communication
disorders, such as dysarthria (Sellars 2005), the lack of large-scale
RCTs in this field is probably because of a combination of factors
including the diversity of the problems, patient compliance, and
a lack of adequate funding. In addition, there are issues that are
pertinent to EPG, such as the time and cost needed for custom-
making an EPG plate for each patient, relatively small number of
suitable candidates for EPG therapy in each individual cleft palate
centre, and the training and support that are needed for the SLTs
to use EPG for articulation assessment and treatment.
Although it appears that conducting a large-scale treatment study
on EPG therapy is difficult due to the obstacles mentioned above,
it is not entirely impossible. In terms of technical issues related to
EPG, there is a recent advancement in the technology of making
EPG plates, which allows the plates to be custom-made in a much
shorter period of time and at a relatively lower cost (Wrench 2007).
Regarding subject recruitment issues, a more centralised cleft care
service may make the process easier and collaboration between
cleft palate centres feasible. For example, in the UK, there has been
a recent nationwide reorganisation of cleft services in England,
Wales, and Northern Ireland, in response to the concerns on cleft
care services and the subsequent review conducted by the research
team of the CSAG (Clinical Standards Advisory Group) Cleft Lip
and Palate Committee (CSAG 1998). The expertise and resources
for cleft care were centralised, resulting in the reduction of 57 cleft
units to 12 regional centres throughout the country. Furthermore,
the conduction of larger scale treatment study could be facilitated
if the infrastructures required are already in place. For example,
in the UK, most of the cleft palate centres are now equipped
with an EPG system and their SLTs had undertaken training on
using EPG for assessment and treatment provided by EPG expert
researchers based atQueenMargaret University (QMU) under the
CLEFTNET project (Lee 2007). The SLTs had also been given
technical support and expert advice on EPG therapy by the QMU
research team. To sum up, these recent developments may help
the conduction of large-scale RCTs on EPG intervention in the
future.
Finally, there are a few recommendations for the planning of EPG
treatment studies in the future. The framework for development
and evaluation of RCTs for complex interventions proposed by
the UKMedical Research Council (MRC 2000) could be applied.
This framework consists five different phases: (1) pre-clinical or
theoretical, (2) Phase I or modelling, (3) Phase II or exploratory
trial, (4) Phase II or main RCT, and (5) Phase IV or long-term
surveillance (MRC 2000). According to this model, the findings
of the included study (Michi 1993), the results reported in previ-
ous case studies and survey (Gibbon 2006), and expert opinions (
Lee 2007) could form the base of the pre-clinical/theoretical phase
for developing an RCT (MRC 2000). Further research is needed
at this point to identify other “active ingredients” for successful
interventions, such as frequency of EPG therapy, clinician char-
acteristics (e.g. experience in EPG therapy), variables related to
the individuals receiving the therapy (e.g. cognitive ability) and so
on, before embarking on an RCT. Once the efficacy of EPG ther-
apy is established, the focus of research could turn to the develop-
ment of a treatment paradigm for enhancing generalisation and
maintenance of treatment effect. Next, cost-effectiveness analysis,
customer satisfaction survey, and quality of life assessment can be
carried out in order to appraise the value of EPG therapy (Robey
1998).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Michi 1993
Methods Randomised controlled trial using parallel group design
Participants 6 participants (4 males and 2 females) aged 4-6 years. 3 of them had unilateral cleft lip
and palate and 3 had bilateral cleft lip and palate. All showed compensatory articulation
errors - palatalized /s/.
Interventions Participants received a 60-minute individual therapy session once per week, except for
1 who had daily treatment:
2 participants received EPG therapy and frication display method;
2 received EPG therapy;
2 received no-visual-feedback.
Therapy targeted fricative /s/.
Outcomes The outcome measures were percent correction production of tongue placement, deter-
mined on the basis of EPG contact pattern, and frication, as by perceptual evaluation
by the second author. The data was collected at the start and end of each session. The
treatment at a certain level continued and did not progress to the next until the partici-
pants achieved at least 80% accuracy. The number of therapy sessions required to attain
each stage for each participants was selectively reported in the Results section.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear The authors stated that “each subject was randomly assigned
and treated by one of the following three methods...” (P. 279).
Randomisation was probably done but the method used for
generating the randomised sequence was not described.
Allocation concealment? No The authors stated that “treatment was carried out by the same
speech-language pathologist” (P. 279). Allocation was probably
not concealed from the healthcare provider.
Blinding?
All outcomes
No Frication production was assessed in real time by the second au-
thor. The speech samples were recorded and played back at ran-
dom to the same author for assessing interjudge agreement; 90%
consistency was reported. The authors did not state whether the
16Electropalatography for articulation disorders associated with cleft palate (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Michi 1993 (Continued)
second author was blinded to treatment allocation at the time
of assessment.
Incomplete outcome data addressed?
All outcomes
Yes No drop-out was reported.
Free of selective reporting? No The authors mentioned measuring percent correct production
for tongue placement and frication for assessing the treatment
progress in the Method section, however, they focused on re-
porting the number of therapy sessions each participant required
to achieve the target for some of the stages of the interventions.
Charts were included to provide additional information on this
but they were difficult to interpret.
Free of other bias? Yes All participants showed the same type of articulation errors be-
fore the intervention began. No early stopping of intervention
and co-intervention were reported.
Characteristics of excluded studies [ordered by study ID]
Dent 1992 Not RCT (case study)
Fujiwara 2007 Not RCT (case study series)
Gibbon 1989 Not RCT (case study)
Gibbon 1998 Not RCT (case study)
Gibbon 2001 Cross-over trial design, which is inappropriate for evaluating speech intervention, was used.
Hardcastle 1989 Not RCT (case study)
Michi 1985 Not RCT (case study)
Michi 1986 Not RCT (case study)
Michi 1990 Not RCT (before and after study, without control group)
Ohira 1989 Not RCT (case study)
Schmidt 2007 Not RCT (case study series)
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(Continued)
Scobbie 2004 Not RCT (case study)
Stokes 1996 Not RCT (case study series)
Whitehill 1996 Not RCT (case study)
Yamashita 1988 Not RCT (case study series)
Yamashita 1999 Not RCT (before and after study, without control group)
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
CENTRAL searched via the Cochrane Library Issue 1, 2008
1. cleft palate
2. electropalatograph*
3. EPG
4. palatograph*
5. palatomet*
6. 2 or 3 or 4 or 5
7. 1 and 6
Appendix 2. MEDLINE search strategy
MEDLINE searched via OCLC 1966 to March 2008
1. cleft
2. palate
3. electropalatograph*
4. EPG
5. palatograph*
6. palatomet*
7. 1 and 2
8. 3 or 4 or 5 or 6
9. 7 and 8
Appendix 3. EMBASE search strategy
EMBASE searched 1974 to March 2008
1. cleft
2. palate
3. electropalatograph*
4. EPG
5. palatograph*
6. palatomet*
7. 1 and 2
8. 3 or 4 or 5 or 6
9. 7 and 8
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Appendix 4. ERIC search strategy
ERIC searched via OCLC 1966 to March 2008
1. cleft
2. palate
3. electropalatograph*
4. EPG
5. palatograph*
6. palatomet*
7. 1 and 2
8. 3 or 4 or 5 or 6
9. 7 and 8
Appendix 5. PsycINFO search strategy
PsycINFO searched via CSA 1967 to March 2008
1. cleft palate
2. electropalatograph*
3. EPG
4. palatograph*
5. palatomet*
6. 2 or 3 or 4 or 5
7. 1 and 6
Appendix 6. CINAHL search strategy
CINAHL searched via Ovid 1982 to March 2008
1. cleft palate
2. electropalatograph*
3. EPG
4. palatograph*
5. palatomet*
6. 2 or 3 or 4 or 5
7. 1 and 6
Appendix 7. Linguistics and Language Behaviour Abstracts search strategy
LLBA searched via CSA 1973 to March 2008
1. cleft palate
2. electropalatograph*
3. EPG
4. palatograph*
5. palatomet*
6. 2 or 3 or 4 or 5
7. 1 and 6
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Appendix 8. Allied and Complementary Medicine search strategy
AMED searched via Ovid 1985 to March 2008
Terms used:
cleft palate
Appendix 9. LILACS search strategy
LILACS searched via Virtual Health Library 1982 to March 2008
Terms used:
cleft palate AND electropalatograph* or EPG or palatograph* or palatomet*
Appendix 10. National Research Register
The National Research Register searched March 2008
Terms used:
electropalatography or EPG or palatometer or palatography
Appendix 11. ClinicalTrials.gov search strategy
ClinicalTrials.gov searched March 2008
Terms used:
electropalatography
Appendix 12. Dissertation Abstracts search strategy
Dissertation Abstracts searched via Digital dissertation consortium 1861 to March 2008
Terms used:
cleft palate AND electropalatography
WH A T ’ S N E W
Last assessed as up-to-date: 8 April 2008.
9 May 2009 Amended Post-hoc change in the protocol -Unit of analysis issues added; cross-over trials considered as inappropriate
for speech intervention.
21Electropalatography for articulation disorders associated with cleft palate (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
H I S T O R Y
Protocol first published: Issue 4, 2007
Review first published: Issue 3, 2009
20 January 2009 Amended Converted to new review format.
9 April 2008 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
FG and AL conducted this review; the searches were run by AL, JL was available for independent assessment of any trials identified,
where necessary. All reviewers contributed to the writing of the protocol and the review.
D E C L A R A T I O N S O F I N T E R E S T
FG has written extensively on this topic.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Post-hoc change in the protocol - a section under ’Unit of analysis’ issues was added and a decision taken that cross-over trials were
considered as inappropriate for speech intervention and would therefore be excluded from this version of the review and from future
updates.
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